Since bottoming out in April 2025, Relay Therapeutics (RLAY) shares have skyrocketed by as much as 1,074%. Now the biotech firm has a fresh breakout in its sights. With its 10-week moving average continuing its long ascent, the Cambridge, Mass.-based company earns a coveted blue dot in MarketSurge, a clear indication of stock market leadership. Biotech Taps AI And Machine…
Copyright ©2026 Investor's Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8